EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Association of the neonatal Fc receptor promoter variable number of tandem repeat polymorphism with immunoglobulin response in patients with chronic inflammatory demyelinating polyneuropathy

Anna Lena Fisse iD, Emelie Schäfer, Alina Hieke, Maximilian Schröder, Rafael Klimas iD, Jil Brünger, Sophie Huckemann, Thomas Grüter iD, Melissa Sgodzai, Christiane Schneider-Gold, Ralf Gold, Huu Phuc Nguyen und 3 weitere

European Journal of Neurology · 2024

DOI: 10.1111/ene.16205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Anna Lena Fisse und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, St. Josef-Hospital, Ruhr University Bochum, Bochum, Germany. Hauptthemen laut MEDLINE: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Receptors, Fc, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disease with humoral and cellular autoimmunity causing demyelination of peripheral nerves, commonly treated with intravenous immunoglobulins (IVIg). The neonatal Fc receptor (FcRn), encoded by the FCGRT gene, prevents the degradation of immunoglobulin G (IgG) by recycling circulating IgG. A variable number of tandem repeat (VNTR) polymorphism in the promoter region of the FCGRT gene is associated with different expression levels of mRNA and protein. Thus, patients with genotypes associated with relatively low FcRn expression may show a poorer treatment response to IVIg due to increased IVIg degradation.

Methods

VNTR genotypes were analyzed in 144 patients with CIDP. Patients' clinical data, including neurological scores and treatment data, were collected as part of the Immune‐Mediated Neuropathies Biobank registry.

Results

Most patients ( n = 124, 86%) were VNTR 3/3 homozygotes, and 20 patients (14%) were VNTR 2/3 heterozygotes. Both VNTR 3/3 and VNTR 2/3 genotype groups showed no difference in clinical disability and immunoglobulin dosage. However, patients with a VNTR 2 allele were more likely to receive subcutaneous immunoglobulins (SCIg) than patients homozygous for the VNTR 3 allele (25% vs. 9.7%, p = 0.02) and were more likely to receive second‐line therapy (75% vs. 54%, p = 0.05).

Conclusions

The VNTR 2/3 genotype is associated with the administration of SCIg, possibly reflecting a greater benefit from SCIg due to more constant immunoglobulin levels without lower IVIg levels between the treatment circles. Also, the greater need for second‐line treatment in VNTR 2/3 patients could be an indirect sign of a lower response to immunoglobulins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyradiculoneuropathy, Chronic Inflammatory DemyelinatingReceptors, FcHistocompatibility Antigens Class IInfant, NewbornHumansImmunoglobulins, IntravenousMinisatellite RepeatsImmunoglobulin GPromoter Regions, Genetic

Stichwörter der Autor:innen

FCGRTEfgartigimodFc gamma receptor and transportergenetic variationimmunoglobulin receptor

Substanzen

Immunoglobulins, IntravenousFc receptor, neonatalImmunoglobulin GReceptors, FcHistocompatibility Antigens Class I

Autor:innen und Institutionen

  • Department of Neurology, St. Josef-Hospital, Ruhr University Bochum, Bochum, Germany.
  • Immune-Mediated Neuropathies Biobank, Ruhr University Bochum, Bochum, Germany.
  • Department of Human Genetics, Ruhr University Bochum, Bochum, Germany.

ORCID-Profile: Anna Lena Fisse, Rafael Klimas, Thomas Grüter, Jeremias Motte

Zitieren

APA

Fisse, A. L., Schäfer, E., Hieke, A., Schröder, M., Klimas, R., Brünger, J., Huckemann, S., Grüter, T., Sgodzai, M., Schneider-Gold, C., Gold, R., Nguyen, H. P., Pitarokoili, K., Motte, J., & Arning, L. (2024). Association of the neonatal Fc receptor promoter variable number of tandem repeat polymorphism with immunoglobulin response in patients with chronic inflammatory demyelinating polyneuropathy. European Journal of Neurology. https://doi.org/10.1111/ene.16205

Vancouver

Fisse AL, Schäfer E, Hieke A, Schröder M, Klimas R, Brünger J, et al. Association of the neonatal Fc receptor promoter variable number of tandem repeat polymorphism with immunoglobulin response in patients with chronic inflammatory demyelinating polyneuropathy. European Journal of Neurology. 2024. doi:10.1111/ene.16205

BibTeX
@article{Fisse2024,
  author = {Fisse, Anna Lena and Schäfer, Emelie and Hieke, Alina and Schröder, Maximilian and Klimas, Rafael and Brünger, Jil and Huckemann, Sophie and Grüter, Thomas and Sgodzai, Melissa and Schneider-Gold, Christiane and Gold, Ralf and Nguyen, Huu Phuc and Pitarokoili, Kalliopi and Motte, Jeremias and Arning, Larissa},
  title = {Association of the neonatal Fc receptor promoter variable number of tandem repeat polymorphism with immunoglobulin response in patients with chronic inflammatory demyelinating polyneuropathy},
  journal = {European Journal of Neurology},
  year = {2024},
  doi = {10.1111/ene.16205}
}
Kostenlos starten →